Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Zhao Zhong

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Annals of Surgical Oncology|August 15, 2023
ASO Author Reflections: Expression Changes in Programmed Death Ligand 1 in Subcentimeter Lung AdenocarcinomaXiongwen Yang, Wen-Zhao Zhong
Journal of Thoracic Disease|February 17, 2017
Translational significance of multi-dimensional omicsJia-Tao Zhang, Wen-Zhao Zhong
The Lancet. Oncology|March 7, 2018
Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer - Authors' replyYi-Long Wu, Wen-Zhao Zhong
Annals of Surgical Oncology|March 30, 2020
ASO Author Reflections: Lung Adenocarcinoma with Accidental Invisible Pleural Dissemination Lesions: Wait-and-See Strategy for Tumors with Indolent Biologic CharacteristicsWen-Fang Tang, Wen-Zhao Zhong
Cancer Communications (London, England)|March 10, 2021
Neoadjuvant immunotherapy for non-small cell lung cancer: State of the artJin Kang, Chao Zhang, Wen-Zhao Zhong
Oncotarget|October 21, 2017
The resistance mechanisms and treatment strategies for <i>EGFR</i>-mutant advanced non-small-cell lung cancerWen-Zhao Zhong, Qing Zhou, Yi-Long Wu
JTCVS Open|January 2, 2023
Potential benefited population for sublobar resectionRui Fu, Yi-Long Wu, Wen-Zhao Zhong
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2019
Rapid Postoperative Relapse in ALK-Positive Locally Advanced NSCLC Patient with Complete Pathological Response to Neoadjuvant CrizotinibChao Zhang, Yi-Long Wu, Wen-Zhao Zhong
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2022
New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019Chao Zhang, Yi-Long Wu, Wen-Zhao Zhong
Journal of Thoracic Disease|March 14, 2019
The superstars of precision medicine-EGFR inhibitors in adjuvant treatment of lung cancerJin Xia, Wen-Zhao Zhong, Yi-Long Wu
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Annals of Surgical Oncology|August 15, 2023
ASO Author Reflections: Expression Changes in Programmed Death Ligand 1 in Subcentimeter Lung AdenocarcinomaXiongwen Yang, Wen-Zhao Zhong
Journal of Thoracic Disease|February 17, 2017
Translational significance of multi-dimensional omicsJia-Tao Zhang, Wen-Zhao Zhong
The Lancet. Oncology|March 7, 2018
Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer - Authors' replyYi-Long Wu, Wen-Zhao Zhong
Annals of Surgical Oncology|March 30, 2020
ASO Author Reflections: Lung Adenocarcinoma with Accidental Invisible Pleural Dissemination Lesions: Wait-and-See Strategy for Tumors with Indolent Biologic CharacteristicsWen-Fang Tang, Wen-Zhao Zhong
Cancer Communications (London, England)|March 10, 2021
Neoadjuvant immunotherapy for non-small cell lung cancer: State of the artJin Kang, Chao Zhang, Wen-Zhao Zhong
Oncotarget|October 21, 2017
The resistance mechanisms and treatment strategies for <i>EGFR</i>-mutant advanced non-small-cell lung cancerWen-Zhao Zhong, Qing Zhou, Yi-Long Wu
JTCVS Open|January 2, 2023
Potential benefited population for sublobar resectionRui Fu, Yi-Long Wu, Wen-Zhao Zhong
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2019
Rapid Postoperative Relapse in ALK-Positive Locally Advanced NSCLC Patient with Complete Pathological Response to Neoadjuvant CrizotinibChao Zhang, Yi-Long Wu, Wen-Zhao Zhong
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2022
New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019Chao Zhang, Yi-Long Wu, Wen-Zhao Zhong
Journal of Thoracic Disease|March 14, 2019
The superstars of precision medicine-EGFR inhibitors in adjuvant treatment of lung cancerJin Xia, Wen-Zhao Zhong, Yi-Long Wu
Pageof 22